Lilly said to be willing to pay $3.7B for biotech firm
A newspaper says Eli Lilly and Co. is a leading contender to acquire a Massachusetts-based biotech company with a troubled leukemia drug.
Life Science & Biotech
Articles
My own Obamacare math says small employers will, indeed, drop coverage
In my financial situation, I could save from 2 percent to 30 percent buying health insurance on the Obamacare exchanges. I suspect a lot of small companies and their workers will see similar results.
Hopelessly divided Congress agrees on one thing: Cutting payments to providers
Congress’ recent willingness to play hardball with providers is driving providers to cautiously embrace concepts—like pay-for-performance and keeping patients out of the hospitals—they have long resisted.
OK, I’m convinced: Hospitals actually are transforming
There are clear signs that hospitals nationally, and even here in Indianapolis, are actually starting to make good on their promises to keep patients healthier and out of the hospital.
Looks like both sides are wrong about Medicaid
New research shows that expanding Medicaid won’t save money, in spite of the claims of Obamacare supporters, but it will provide modest help to patients’ health and pocketbooks, in spite of conservative critics’ contention to the contrary.
IU professors’ invention tracks eyes to detect brain injuries
Two Indiana University School of Optometry professors are tackling diagnosis of one of the most difficult medical problems facing sports teams at every level: head injuries.
Funding drought pinches life sciences firms
Nationally, venture capital investments into life sciences firms totaled $4.9 billion during the first nine months of 2013, down 30 percent from the same period in 2008, according to data from Thomson Reuters and PricewaterhouseCoopers. In Indiana, life sciences firms raised $21 million during the first nine months of the year, far lower than any year since 2003.
Crux of Medicaid showdown is how to fight poverty
When Gov. Mike Pence tries next month to negotiate a Medicaid expansion deal in a meeting with the Obama administration, it will be a clash of the conservative and liberal approaches to fighting poverty.
State lags city with science, tech jobs
Careers in science, technology, engineering and math—typically referred to as STEM fields—have surged in growth compared to other careers in Marion and Hamilton counties. But the rest of Indiana has barely budged from the early 2000s.
No one likes Obamacare
Obamacare has officially arrived, but both conservatives and liberals are calling it awful. That means the real debate over health reform is just beginning.
For the holidays: A hopeful, health care reading list
In the Christmas spirit of hope, I’m offering a reading list of several optimistic reports about health care reform—even though many of my recent posts, and the mood of the country in general, have been decidedly downbeat.
Medicare names names on hospital quality, but don’t expect consumers to notice
The Obama administration has been releasing more price and quality information, but it is coming in a rather useless form for patients. That’s a problem for the prospects of consumer-driven health care.
Sorry, docs, but Obamacare will suffer from a shortage
There is good evidence that new technology deployed via new methods of medicine across the entire health care system can reduce the need for physicians. But there are too many barriers for such changes to occur in time to cut off the surge in demand brought on by Obamacare.
Obama team willing to ‘Republicanize’ Medicaid, but maybe not enough for Indiana
A new Medicaid expansion deal with the Republican governor of Iowa OK’d a cost-sharing requirement similar to what Indiana Gov. Mike Pence wants. But the Obama administration says it won’t extend that deal as low as Pence would like to go.
Lilly set to fall off second patent cliff
Eli Lilly and Co. on Wednesday will fall off its second “patent cliff” in as many years as its best-selling drug Cymbalta sees its U.S. patents expire.
What if exchange enrollment never catches up?
Based on some very rough assumptions, I calculate that Hoosiers could see premiums 14 percent to 28 percent higher in 2015, due in part to low enrollment in the Obamacare exchanges in 2014.
Hospitals figure out their own way to game Obamacare’s tax subsidies
In response to insurers’ “zero-premium” strategy, hospitals figure out their own way to game the tax subsidies available in the new Obamacare exchanges: pay premiums for their patients.
Blurring the line between health care and health insurance
IU Health is working with a hospital-based health plan in Pittsburgh that is now directly challenging the Blue Cross health plan there. Could the same thing happen here?
Why insurers want to limit your choice of doctor
In spite of President Obama’s promises that if you like your doctor, you can keep your doctor, the president’s health reform law is spurring health insurers to make him a liar on that point too.